Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).
Erttmann R, Tafese T, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Ambros P, Christiansen H, Favrot M, Kabisch H, Hero B, Philip T. Erttmann R, et al. Among authors: kabisch h. Eur J Cancer. 1998 Aug;34(9):1391-7. doi: 10.1016/s0959-8049(98)00135-x. Eur J Cancer. 1998. PMID: 9849422
Screening for neuroblastoma.
Schilling FH, Erttmann R, Ambros PF, Strehl S, Christiansen H, Kovar H, Kabisch H, Treuner J. Schilling FH, et al. Among authors: kabisch h. Lancet. 1994 Oct 22;344(8930):1157-8. doi: 10.1016/s0140-6736(94)90665-3. Lancet. 1994. PMID: 7934514 No abstract available.
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ. Zander AR, et al. Among authors: kabisch h. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2671-5. Clin Cancer Res. 1997. PMID: 10068272 Clinical Trial.
Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation.
Horstmann M, Kroschke G, Stockschläder M, Betker R, Krüger W, Erttmann R, Kabisch H, Zander A. Horstmann M, et al. Among authors: kabisch h. Pediatr Hematol Oncol. 1996 Jan-Feb;13(1):45-53. doi: 10.3109/08880019609033371. Pediatr Hematol Oncol. 1996. PMID: 8718502
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F, Henze G, Jürgens H, Kabisch H, Havers W, Reiter A, Kluba U, Niggli F, Gadner H. Creutzig U, et al. Among authors: kabisch h. J Clin Oncol. 2001 May 15;19(10):2705-13. doi: 10.1200/JCO.2001.19.10.2705. J Clin Oncol. 2001. PMID: 11352963 Clinical Trial.
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR. Kröger N, et al. Among authors: kabisch h. Bone Marrow Transplant. 1998 Dec;22(11):1029-33. doi: 10.1038/sj.bmt.1701498. Bone Marrow Transplant. 1998. PMID: 9877263
125 results